A theranostic approach for CAR-T cell therapy.

Fibroblast activation protein (FAP) is frequently expressed in the tumor stroma, whereas expression by normal organs is highly restricted. Despite these promising features, FAP targeted therapies have shown limited success so far. FAP imaging offers new opportunities to select patients for FAP targeted therapies and monitor tumor response.